{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:42:01Z","timestamp":1779324121832,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejpn.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T08:16:33Z","timestamp":1415175393000},"page":"75-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Andreas","family":"Peyrl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn-Sven","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Ebell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Hern\u00e1iz Driever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.10.004_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpn.2012.10.008","article-title":"Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram\u2013a pilot study","volume":"17","author":"Goldberg-Stern","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2014.10.004_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.seizure.2011.04.004","article-title":"Levetiracetam monotherapy-outcomes from an epilepsy clinic","volume":"20","author":"Stephen","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2014.10.004_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.V100.2.427","article-title":"Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation","volume":"100","author":"Barnard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejpn.2014.10.004_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2011.11.009","article-title":"Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia","volume":"18","author":"Kobos","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ejpn.2014.10.004_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00043426-200312000-00010","article-title":"Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients","volume":"25","author":"Woodard","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejpn.2014.10.004_bib6","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1200\/JCO.2012.48.5680","article-title":"Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group","volume":"31","author":"Eckert","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejpn.2014.10.004_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejpn.2014.10.004_bib8","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2014.10.004_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejpn.2014.10.004_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pbc.24126","article-title":"Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation","volume":"59","author":"Soni","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejpn.2014.10.004_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1345\/aph.1L727","article-title":"Levetiracetam-induced pancytopenia","volume":"43","author":"Elouni","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejpn.2014.10.004_bib12","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/j.1528-1167.2010.02788.x","article-title":"Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study","volume":"51","author":"Sahaya","year":"2010","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T20:54:20Z","timestamp":1538081660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1090379814001731"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.10.004","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}